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The performance of molecular tests using the Verigene Gram-Positive and Gram-Negative Blood Culture nucleic acid tests (BC-GP
and BC-GN, resp.; Naosphere, Northbrook, IL, USA) was evaluated for the identification of microorganisms detected from blood
cultures. Ninety-nine blood cultures containing Gram-positive bacteria and 150 containing Gram-negative bacteria were analyzed
using the BC-GP and BC-GN assays, respectively. Blood cultures were performed using the Bactec blood culture system (BD
Diagnostic Systems, Franklin Lakes, NJ, USA) and conventional identification and antibiotic-susceptibility tests were performed
using a MicroScan system (Siemens, West Sacramento, CA, USA). When a single strain of bacteria was isolated from the blood
culture, Verigene assays correctly identified 97.9% (94/96) of Gram-positive bacteria and 93.8% (137/146) of Gram-negative bacteria.
Resistance genes mecA and vanA were correctly detected by the BC-GP assay, while the extended-spectrum 𝛽-lactamase CTX-M
and the carbapenemase OXA resistance gene were detected from 30 cases cultures by the BC-GN assay. The BC-GP and BC-GN
assays showed high agreement with conventional identification and susceptibility tests.These tests are useful for rapid identification
of microorganisms and the detection of clinically important resistance genes from positive Bactec blood cultures.
1. Introduction
Prompt medication with suitable antibiotics has a consid-
erable effect on mortality rates in patients suffering from
bloodstream infections [1, 2]. In cases of septic shock, hours of
delay in antimicrobial administration significantly increased
mortality rate [3]. Therefore, of all bacterial culture tests,
blood culture tests place the most emphasis on speed [4].
While conventional blood culture requires extended
times for subculture, identification, and susceptibility testing,
the use of molecular technologies as adjuvants during the
blood culture process enables rapid identification of pathogen
and antibiotic resistance, enabling patients to receive the
appropriate treatment [5, 6].
The Verigene Gram-Positive Blood Culture (BC-GP)
and Gram-Negative Blood Culture (BC-GN) nucleic acid
tests (Nanosphere, Northbrook, IL, USA) are microarray-
based assays capable of testing multiple bacterial pathogens
and their antibiotic resistance simultaneously. The times of
identification of microorganisms in positive blood culture
broth are less than 2.5 hours with the Verigene assays. The
BC-GP assay is composed of 12 bacterial targets and three
resistancemarkers. It has been used clinically for several years
in the US and many other countries, and its utility has been
evaluated in multiple studies [6–9]. The BC-GN research-
use-only assay was originally composed of nine bacterial
targets and six resistance markers [10, 11], but the recently
FDA-cleared version of BC-GN test is composed of only eight
bacterial targets and six resistance markers and has become
available as an in vitro diagnostic (IVD) test. In this study, we
aimed to evaluate the performance of FDA-cleared versions
of the BC-GP and BC-GN assays for the identification of
Gram-positive and Gram-negative bacteria showing positive
responses in the Bactec blood culture system (BD Diagnostic
Systems, Franklin Lakes, NJ, USA).
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2. Materials and Methods
2.1. Specimens. Two hundred and forty-nine positive blood
cultures were analyzed from patients admitted to Kandgond
Sacred-Heart Hospital in Seoul from March 2014 to June
2015. Duplicated blood cultures from the same patients were
excluded. Gram-positive bacteria were cultured from 99
samples andGram-negative bacteria from 150 samples. Blood
specimens were inoculated into Bactec-plus aerobic/F and
anaerobic/F bottles (BD Diagnostic Systems) and incubated
in the Bactec Fx instrument (BD Diagnostic Systems).
2.2. Verigene Assays. Gram stains were performed on the
samples exhibiting a positive signal for the automated blood
culture system. The BC-GP and BC-GN assays were per-
formed and the results were analyzed followingmanufacturer
instructions. A test cartridge, utility tray, and extraction
tray were loaded into the Verigene Processor Sp. 700 𝜇L of
positive blood culturewas added to the extraction tray sample
well. Nucleic acids from positive culture were extracted and
hybridized to microarray. After 2 hours, the microarray was
transferred to the Verigene Reader for analysis [12].
2.3. Conventional Identification and Antibiotic-Susceptibility
Testing. For positive blood cultures, subculturing was per-
formed on blood-agar plates. Following overnight incuba-
tion, a pure colony was picked from the subculture for
identification and susceptibility testing. The identification of
Gram-positive bacteria and the susceptibility test were con-
ducted usingMicroScan PosCombo 28,MicroScan StrepPlus
Panels, and MicroScan Walkaway-96 System (Siemens, West
Sacramento, CA, USA). The identification of Gram-negative
bacteria and susceptibility testing were performed using the
MicroScan Neg BP Combo 42 Panel (Siemens). In the event
of disagreement between results from the Verizone assay
and identification results using the conventional method,
sequence analysis of 16S rRNA [13] and rpoB gene [14] was
performed for Gram-positive bacteria and Klebsiella species,
respectively.
3. Results
3.1.The BC-GPAssay. Among 99 samples fromwhichGram-
positive bacteria were cultured, 96 showed a single strain
(monomicrobial cultures) and three samples showed two
strains of microorganisms (polymicrobial cultures). Among
the 96 samples from which a single strain of Gram-positive
bacteria was isolated, the results of 90 samples (93.8%, 95%
confidence interval [CI]: 88.9%–98.6%) were concordant
between the MicroScan Panel and the BC-GP assay. The BC-
GP assay correctly identified the presence of Staphylococcus
aureus (𝑛 = 22), except for one isolate having “no call”
result (invalid result). Thirty-four Staphylococcus epidermidis
were detected with BC-GP; however, three were identified
as other coagulase-negative staphylococci (CoNS) using
the MicroScan Panel. Twenty-five Staphylococcus spp. were
detected using BC-GP, with one identified as S. epidermidis
by the MicroScan Panel (Table 1). In the case of coagulase-
negative staphylococci, for which the MicroScan Panel and







S. aureus 23 22 23
S. epidermidis 34a 34 31
Staphylococcus spp. 25b 25 24
Streptococcus
S. agalactiae 1 1 1
S. anginosus 1 1 1
Other streptococci 4 4 4
Enterococcus
E. faecalis 5 5 5
E. faecium 2 2 2
E. raffinosus 1c 1
Total 96 94 92
aThree isolates identified Staphylococcus spp. byMicroScan but S. epidermidis
by 16S rRNA sequencing.
bAn isolate identified S. epidermidis by MicroScan but S. hominis by 16S
rRNA sequencing.
cNot included among the targets of Verigene Gram-Positive Blood Culture.
the BC-GP assay showed discordant identification results in
four cases, the BC-GP assay made the accurate identification,
as confirmed by 16S rRNA sequencing. Enterococci were
cultured in eight samples, with seven isolates, except for
Enterococcus raffinosus, which is not included in the BC-GP
assay, exhibiting concordant results between the MicroScan
Panel and the BC-GP assay. The results of six streptococcal
isolates were concordant between the MicroScan Panel and
the BC-GP assay. The BC-GP assay accurately identified
pathogens in 97.9% (94/96, 95% CI: 93.0% to 100%) of the
blood culture samples from which a single Gram-positive
strain was isolated (Table 1).
The BC-GP assay detected the mecA gene from 35 of 57
samples in which S. aureus or S. epidermidis was cultured
alone, which was concordant with MicroScan susceptibility
test results. From the single Enterococcus faecium case that
exhibited vancomycin resistance, the assay detected the vanA
gene (Table 2).
From the three samples in which two strains of microor-
ganisms were cultured, there were differences between the
MicroScan Panel and BC-GP assay results. The BC-GP assay
reported Staphylococcus spp. with mecA-negative result in a
sample containing methicillin-resistant S. aureus and Can-
dida albicans. In a sample containing methicillin-susceptible
S. epidermidis and methicillin-resistant other CoNS, the BC-
GP assay reported result of S. epidermidis with mecA and
Staphylococcus spp. (Table 3).
3.2. The BC-GN Assay. Among the 150 samples from which
Gram-negative bacteria were cultured, 146 showed a single
strain and four showed at least two strains ofmicroorganisms.
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Table 2: Resistance markers detected by the Verigene assays.
Organism Number of isolates Number of resistance markers by the Verigene assays
mecA vanA CTX-M OXA
S. aureus 23 8
S. epidermidis 34 27
E. faecium. 2 1
E. coli 82 14
K. pneumoniae 19 1
Acinetobacter spp. 22 15
Table 3: Results of the Verigene assays in polymicrobial samples (𝑛 = 7).
Case MicroScan result Verigene result
1 S. epidermidis (MRa), Candida albicans Staphylococcus spp.
2 S. epidermidis, Staphylococcus spp. (MR) mecA (+) S. epidermidis, Staphylococcus spp.
3 S. epidermidis (MR), Streptococcus spp. mecA (+) S. epidermidis, Staphylococcus spp., Streptococcus spp.
4 E. coli, K. pneumoniae E. coli, K. pneumoniae
5 E. coli, K. pneumoniae E. coli, K. pneumoniae
6 Enterobacter spp., S. marcescens Enterobacter spp., K. oxytoca
7 Acinetobacter spp., Enterobacter spp., and S. marcescens Acinetobacter spp., Enterobacter spp., and K. oxytoca
aMR, methicillin resistant.
Of the 146 monomicrobial cultures, 138 (94.5%) isolates
belonged to microorganisms included in the BC-GN assay
(Table 4). Escherichia coli was most frequently isolated, with
82 samples (59.4%), followed by Acinetobacter spp. with
22 samples (15.9%), Klebsiella pneumoniae with 19 samples
(13.8%), Enterobacter spp. with four samples (2.9%), Proteus
spp. with four samples (2.9%), Citrobacter spp. with three
samples (2.2%), and finally Klebsiella oxytoca and Pseu-
domonas aeruginosa with two samples each (1.4%). Eight
samples showed microorganisms not included in the BC-GN
assay, of which three samples showed Stenotrophomonas mal-
tophilia, with Aeromonas hydrophila, Burkholderia cepacia,
andMorganella morganii cultured in one sample each. From
two samples, K. pneumoniae was detected by the MicroScan
Panel but failed to be detected by the BC-GN assay. These
isolates were confirmed as Klebsiella variicola by rpoB gene
sequencing.
The overall concordant rates between the BC-GN assay
and the MicroScan Panel for Gram-negative monomicrobial
cultures were 93.8% (137/146, 95% CI: 90.0% to 97.7%), and
99.3% (137/138, 95% CI: 98.6% to 100%) showed concordant
results when only the microorganisms included in the BC-
GN assay were considered (Table 4). One sample, fromwhich
a single strain was subcultured and E. coli was later detected
by the MicroScan Panel, exhibited a positive response for
both E. coli and K. pneumoniae in the BC-GN assay.
Two of the four samples fromwhich at least two strains of
microorganisms were cultured showed a coculture of E. coli
and K. pneumoniae, with the MicroScan Panel and the BC-
GN assay exhibiting concordant results. One sample showed
a coculture of Enterobacter spp. and Serratia marcescens and
exhibited a positive response for Enterobacter spp. and K.
oxytoca in the BC-GN assay. In another sample, the three
Table 4: Identification of the Verigene Gram-Negative Blood





E. coli 82 81 82
K. pneumoniae 19a 19 19
Acinetobacter spp. 22 22 22
Enterobacter spp. 4 4 4
Proteus spp. 4 4 4
Citrobacter spp. 3 3 3
K. oxytoca 2 2 2
P. aeruginosa 1 1 1
Not targeted organism 8b 6
Total 146 137 144
aTwo isolates identified Klebsiella pneumoniae by MicroScan but Klebsiella
variicola by rpoB sequencing.
bIncluded three Stenotrophomonas maltophilia, two K. variicola, one
Aeromonas hydrophila, one Burkholderia cepacia, and one Morganella mor-
ganii.
microorganisms, Acinetobacter spp., Enterobacter spp., and
S. marcescens, were simultaneously cultured, with the BC-
GN assays showing a positive response forAcinetobacter spp.,
Enterobacter spp., and K. oxytoca (Table 3).
Resistance markers were detected from 30 samples with
the BC-GN assay. Among the 84 E. coli samples, 14 exhibited
an extended-spectrum 𝛽-lactamase (ESBL) CTX-M positive
response with the BC-GN assay, while Acinetobacter spp.
exhibited a carbapenemase OXA positive response in 15 of
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Table 5: BC-GN resistance markers and results of antibiotic-susceptibility testing.
BC-GN test gene Organism Antibiotic-susceptibility test
CAZ CTX IPM MEM GEN AMK CIP
CTX-M
E. coli R R S S S S R
E. coli R R S S S I R
E. coli R R S S S S R
E. coli R R S S R S R
E. coli R R S S R S S
E. coli R R S S S I R
E. coli R R S S R S R
E. coli R R S S R S R
E. coli R R S S R S R
E. coli R R S S S S S
E. coli R R S S R S R
E. coli R R S S R S R
E. coli R R S S S S S
E. coli R R S S R S R
K. pneumoniae R R S S S S S
OXA
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R S R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R S R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R S R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R S R
Acinetobacter spp. R R R R R R R
Acinetobacter spp. R R R R R R R
CAZ, ceftazidime; CTX, cefotaxime; IPM, imipenem; MEM, meropenem; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; R, resistant; S, susceptible;
and I, intermediate.
23 cultured samples, and K. pneumoniae exhibited a CTX-
M positive response in one of 23 cultured samples (Table 2).
All CTX-M positive isolates (E. coli, K. pneumoniae) were
resistant to cephalosporins and susceptible to carbapenems,
and all OXA positive isolates (Acinetobacter spp.) showed
multidrug resistant phenotype by antibiotic-susceptibility
testing (Table 5).
4. Discussion
Many studies have evaluated the performance of the BC-
GP and BC-GN assays for the prompt detection of bacterial
pathogens and resistance markers from positive blood cul-
tures [6–12]. Most studies have only evaluated either the BC-
GP assay or the BC-GN assay and have assayed simulated
specimens, which were made from preserved isolates, along
with fresh or frozen specimens. This study tested the perfor-
mance of both the BC-GP and BC-GN assays targeting fresh
clinical specimens using the Bactec blood culture system.
TheBC-GP assay has been appraised for superior identifi-
cation and resistancemarker detection frommonomicrobial-
positive blood cultures [6–8]. We demonstrated that the BC-
GP assay results were accurate in 97.9% of the samples in
which a single strain of Gram-positive bacteria was cultured.
The BC-GP assay also efficiently detected themecA and vanA
genes from samples in which a single strain of Gram-positive
bacteria was cultured.
A previous study reported that one of 20 K. pneumoniae
isolates was not detected by the BC-GN assay [9], and
another study reported failure to detect two of 14 isolates [11].
Recently, the BC-GN assay exhibited false-negative results
most frequently for K. variicola, and it was speculated that
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it might be wrongly identified as K. pneumoniae during
biochemical identification [12]. K. variicola is phenotypically
similar to K. pneumoniae and has been frequently isolated
from clinical specimens since the introduction of molecular
detection methods [15, 16]. The BC-GN assay failed in two
samples to detect K. pneumoniae, which was identified by the
MicroScan Panel.We identified the two isolates ofK. variicola
which weremisidentified asK. pneumoniae by theMicroScan
Panel in this study.
In one sample, although theMicroScan Panel identifiedE.
coli, the BC-GNassay exhibited a positive response for bothE.
coli and K. pneumoniae. The analytical sensitivity of the BC-
GN assay is 105–107 colony-forming units (CFUs), which is
sensitive when compared to the count number for a positive
response from a blood culture bottle (108–109 CFUs) [17]. It
is possible that the conventional culture only isolated E. coli
due to the insufficient number of K. pneumoniae present in
the blood culture bottle.
The BC-GN assay has the disadvantage of not including
as detection targets Gram-negative microorganisms that are
frequently isolated [12]. In this study, 5.5% of Gram-negative
isolates cultured as a single strain were microorganisms
not included in the BC-GN assay and, therefore, were only
capable of being identified with the MicroScan Panel.
The BC-GN assay was able to detect resistance markers
for CTX-M and OXA from 30 samples. While earlier studies
detected resistance markers from stored bacterial strains, we
were able to validate the ability of the BC-GN assay to detect
resistance markers from clinical specimens.
The BC-GN assay is designed to detect 6 common
resistant genes, but there are other resistance genes andmech-
anisms. The negative results for any of resistance markers by
the BC-GN assay cannot exclude a resistant isolate.
The accuracy of the BC-GP and BC-GN assays has been
reported to be relatively low for the direct identification of
microorganisms in polymicrobial cultures [6, 12]. The same
issue exists in matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry or other molecular assays,
such as the FilmArray blood culture identification (BioFire
Diagnostics, Salt Lake City, UT) [18, 19]. Among the 249
samples in this study, seven (2.8%) exhibited polymicrobial
culture results.Therewas disagreement in the results between
the Verigene assay and the MicroScan Panel in five of the
seven samples. Polymicrobial results from Verigene assays
should be confirmed by conventional identification and
antimicrobial susceptibility test.
In conclusion, the BC-GP and BC-GN assays demon-
strated high analytical accuracy for clinical specimens and
exhibited consistent results with conventional identification
and sensitivity tests. Employing these tests in positive Bactec
blood cultures will be useful for the rapid identification of
microorganisms and the detection of clinically important
resistance genes.
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